Suliman Shehnaazinsider trades
In SEC Form 4 filings, Suliman Shehnaaz is listed as Director of 10x Genomics, Inc. (TXG). In the last 90 days, Suliman Shehnaaz sold $605.1K of 10x Genomics, Inc. (TXG) on the open market and bought none. All 7 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| TXG10x Genomics, Inc. | Director | 7 | Sep 24 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-26
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| TXG10x Genomics, Inc. | Sep 22 | Sep 24 | S | 292 | $78.20 | Sale −$22,833 | 29,223 | Yes | Form 4 |
| TXG10x Genomics, Inc. | Sep 22 | Sep 24 | S | 614 | $79.51 | Sale −$48,820 | 28,609 | Yes | Form 4 |
| TXG10x Genomics, Inc. | Sep 22 | Sep 24 | S | 1,325 | $80.82 | Sale −$107,082 | 27,284 | Yes | Form 4 |
| TXG10x Genomics, Inc. | Sep 22 | Sep 24 | S | 2,270 | $81.67 | Sale −$185,391 | 25,014 | Yes | Form 4 |
| TXG10x Genomics, Inc. | Sep 22 | Sep 24 | S | 1,222 | $82.28 | Sale −$100,542 | 23,792 | Yes | Form 4 |
| TXG10x Genomics, Inc. | Aug 24 | Aug 26 | S | 561 | $62.73 | Sale −$35,189 | 31,161 | Yes | Form 4 |
| TXG10x Genomics, Inc. | Aug 24 | Aug 26 | S | 1,646 | $63.97 | Sale −$105,289 | 29,515 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.